OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the American College of Cardiology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Sparking the Fire in Adult Congenital Heart Disease	1450
Shining a New Light Into the Black Box	1098
Quantitative Myocardial Perfusion Predicts Outcomes in Patients With Prior Surgical Revascularization	897
Audio Summary	718
HYPERTROPHIC CARDIOMYOPATHY WITH SUBENDOCARDIAL ISCHEMIA MIMICKING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION	549
ISOLATED CARDIAC SARCOIDOSIS: A SINGLE CENTER REVIEW OF CLINICAL MANIFESTATIONS AND OUTCOMES	499
EFFECTS OF AUTOANTIBODY AGAINST M2-MUSCARINIC ACETYLCHOLINE RECEPTOR IN PERIPARTUM CARDIOMYOPATHY PATIENTS ON DIGOXIN ADDITIONAL TO STANDARD TREATMENT	499
RECURRENT REVERSE TAKOTSUBO- AN ENIGMA INDEED	413
RISK PREDICTION IN PULMONARY HYPERTENSION DUE TO CHRONIC HEART FAILURE	376
NON-VITAMIN K ANTAGONISTS SHOULD BE PREFERRED OVER WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND BIOPROSTHETIC VALVES: A SYSTEMATIC REVIEW AND META-ANALYSIS	344
IS RENIN ANGIOTENSIN SYSTEM MODULATION BENEFICIAL IN HEART FAILURE PATIENTS WITH END-STAGE RENAL DISEASE	327
WORSE OUTCOMES IN OLDER ADULTS WITH COMORBID HEART FAILURE COMPLICATING RESPIRATORY SYNCYTIAL VIRUS INFECTION	293
PROPER USE OF CHRONIC TOTAL OCCLUSIONS (CTO) HYBRID ALGORITHM TO SECURE LEFT MAIN DISSECTION	293
A RARE CASE OF CHONDROSARCOMA WITH CARDIAC METASTASIS	290
CARDIAC MASS IN A PATIENT WITH RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA WITH NONDIFFUSE BONE MARROW INVOLVEMENT	281
ASSOCIATION OF AGE WITH ORAL ANTICOAGULANT PRESCRIPTION AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM A UNITED STATES COMMERCIAL CLAIMS DATABASE	249
CORONARY FLOW RESERVE AND STRESS MYOCARDIAL BLOOD FLOW ACROSS THE SPECTRUM OF AORTIC STENOSIS	248
TCTAP A-075 Effects of Silver Nanoparticles in Isoproterenol-Induced Myocardial Infarction	240
SHINGLE-VACCINE ASSOCIATED MYOCARDITIS-A CASE REPORT	240
DOUBLE TROUBLE: NEW ONSET DYNAMIC LVOT OBSTRUCTION AFTER TAVR	237
AFRICAN AMERICAN WITH ATRIAL FIBRILLATION (AF) AND HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) ARE AT HIGHER RISK OF MORTALITY	235
PERCUTANEOUS CORONARY INTERVENTION OUTCOMES IN PATIENTS WITH LIVER CIRRHOSIS A META ANALYSIS	233
TCTAP C-022 Shock the Rock- Intravascular Lithotripsy Assisted PCI of an Extremely Calcific Right Coronary Artery	231
OUTPATIENT CARDIOVASCULAR ASSESSMENT AND IMAGING FOLLOWING THE DIAGNOSIS OF COVID-19 IN US NAVAL ACADEMY CADETS	226
THE GREAT MIMICKER: IMMUNE CHECKPOINT INHIBITOR INDUCED MYOCARDITIS	224

LUNG INJURY AND FUNCTIONAL CAPACITY POST-SARS-COV-2 INFECTION	212
ATRIAL FIBRILLATION ABLATION IS ASSOCIATED WITH CHANGES IN LEFT ATRIAL APPENDAGE AND LEFT ATRIAL ANATOMY	196
A RARE CASE OF PERSISTENT THEBESIAN VEIN SYNDROME MASQUERADING CONSTRICTIVE PERICARDITIS	193
GEOGRAPHIC DISTRIBUTION AND CLINICAL OUTCOMES AMONG PATIENTS WITH TRANSCATHETER MITRAL VALVE REPAIR IN THE UNITED STATES	190
PERICARDIAL EFFUSION REQUIRING CATHETER OR SURGICAL BASED INTERVENTION IN PATIENTS IMPLANTED WITH WATCHMAN PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION IN THE UNITED STATES	182
FORGOTTEN BUT NEVER GONE, CARDIAC BERIBERI	179
ADVERSE PROGNOSTIC PREDICTORS AMONG PATIENTS PRESENTING WITH OUT-OF-HOSPITAL CARDIAC ARREST AND A SHOCKABLE RHYTHM	177
INTRAVASCULAR ULTRASOUND GUIDED ZERO CONTRAST PERCUTANEOUS CORONARY INTERVENTION IN CHRONIC KIDNEY DISEASE PATIENTS: FEASIBILITY AND SHORT TERM OUTCOME	175
LONG-TERM OUTCOMES OF HEART TRANSPLANTATION AND LEFT VENTRICULAR ASSIST DEVICES IN PATIENTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS: A SYSTEMATIC REVIEW AND META-ANALYSIS	174
MEMBRANOUS SEPTUM LENGTH PREDICTS NEW CONDUCTION ABNORMALITIES AFTER SURGICAL AORTIC VALVE REPLACEMENT	170
TCTAP C-172 Case Report: Refractory Chest Pain After Transcatheter Aortic Valve Implantation	159
MEASURING THE BOUNDARY LAYERS IN PATIENTS WITH ACUTE CORONARY SYNDROME BY DYNAMIC ANGIOGRAPHY AND MACHINE LEARNING PROGRAM	159
MEDICAL STUDENT LEADERSHIP GROUP CONVENED BY THE AMERICAN COLLEGE OF CARDIOLOGY	156
A RAPIDLY GROWING MASS AND UNUSUAL GAS IN AN ORTHOTOPIC HEART TRANSPLANT PATIENT	155
PLASMA DESMOSINE, A BIOMARKER OF ELASTIN DEGRADATION, PREDICTS OUTCOMES IN ACUTE MYOCARDIAL INFARCTION	150
AN UNEXPECTED FINAL DIAGNOSIS IN A PATIENT WITH REFRACTORY ANGINA AND ELECTRICAL STORM	149
Full Issue PDF	147
THE EFFECT OF DIABETES MELLITUS, PREDIABETES AND GLYCEMIA ON LEFT VENTRICULAR ASSIST DEVICE-MEDIATED CARDIAC RECOVERY	147
THE JAILED SINOATRIAL NODE: SINUS ARREST-INDUCED CARDIOGENIC SHOCK FOLLOWING PERCUTANEOUS INTERVENTION	145
PHARMACOLOGICAL INHIBITION OF BAG3-HSP70 WITH THE PROPOSED CANCER THERAPEUTIC JG-98 IS TOXIC FOR CARDIOMYOCYTES: IN-VIVO PILOT STUDY	144
RATE AND CAUSES OF 30-DAY READMISSION AFTER IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PLACEMENT: ANALYSIS OF NATIONAL INPATIENT SAMPLE	144
DERIVATION AND VALIDATION OF A RISK STRATIFICATION TOOL IN PATIENTS WITH TYPE 2 MYOCARDIAL INFARCTION	137
TREATMENT OF ASYMPTOMATIC DONOR SPECIFIC ANTIBODY AFTER HEART TRANSPLANTATION: IS IT BENEFICIAL?	136
CARDIAC MYXOMAS: CLINICAL CHARACTERISTICS AND OUTCOMES FROM A HIGH-VOLUME CENTER	136
CAUGHT IN THE ACT: MINOCA IN A PATIENT WITH SEVERE CORONARY VASOSPASM	133
A RARE CASE OF EARLY CARDIAC TAMPONADE CAUSED BY SEVERE POSTOPERATIVE HYPOTHYROIDISM TWO YEARS AFTER OPERATION	131
THE EFFECTS OF EMPAGLIFLOZIN AND ORAL KETONE ESTER ON CARDIAC FUNCTION, STRUCTURE, AND METABOLISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION	129
PATIENT-REPORTED OUTCOMES IN CLINICAL STUDIES OF PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES	127
NON-INVASIVE ASSESSMENT OF MYOCARDIAL ENERGETICS USING 11-C ACETATE POSITRON EMISSION TOMOGRAPHY: SYSTEMATIC REVIEW AND META-ANALYSIS	127
THE ASSOCIATION OF ATRIAL UPTAKE AND ATRIAL FIBRILLATION IN PATIENTS WITH SUSPECTED CARDIAC AMYLOIDOSIS	126
IMPACT OF MALNUTRITION BY GERIATRIC NUTRITIONAL RISK INDEX IN ELDER PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICE: AN INTERMACS ANALYSIS	125
ANOMALOUS ORIGIN AND PRESENTATION: A GIANT CORONARY ANEURYSM CAUSING CHEST PAIN	125
SEA ANEMONE TUMOR OF THE AORTA PRESENTING WITH DYSPNEA IN A WOMAN	124
ACUTE MYOCARDIAL INJURY (AMI) MIMICKING ACUTE CORONARY SYNDROME (ACS) IN THE SETTING OF METHANOL TOXICITY	124
TCTAP C-180 Atrial Septal Defect With Desaturation in an Elderly Patient : Need to Closed	123
PAPILLARY MUSCLE ABNORMALITY AS AN ELECTROCARDIOGRAPHIC MIMICKER OF APICAL HYPERTROPHIC CARDIOMYOPATHY	122
CARDIOVASCULAR DISEASE DIAGNOSIS USING CARDIOVASCULAR IMAGING AND ARTIFICIAL INTELLIGENCE	122
TCTAP C-183 Device-Related Hemolytic Anemia After Transcatheter Closure of a Ruptured Ventricular Septum: To Wait or to Act?	121
REAL-WORLD PERFORMANCE AND VALIDATION OF THE ARTIFICIAL INTELLIGENCE ENHANCED ELECTROCARDIOGRAM FOR THE DETECTION OF AMYLOIDOSIS	120
TCTAP C-189 A Challenging Case Report: Transcatheter Occulsion One Coronary Artery Fistula From Right Coronary Artery to Left Ventricule	118
GENDER DISPARITY IN CLINICAL OUTCOMES IN PATIENTS WITH TAKOTSUBO CARDIOMYOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS.	116
EOSINOPHILIC MYOCARDITIS AND LOEFFLER ENDOCARDITIS IN THE SETTING OF HYPEREOSINOPHILIC SYNDROME: DEMOGRAPHICS, CARDIAC IMAGING, MANAGEMENT AND OUTCOMES	116
IS SYSTOLIC AND DIASTOLIC FUNCTION INCLUDING GLOBAL LONGITUDINAL STRAIN BY ECHOCARDIOGRAPHY COMPROMISED IN ADULT PATIENTS TREATED WITH CD19 CAR T-CELL THERAPIES FOR HEMATOLOGICAL MALIGNANCIES IN THOSE	116
ECHOCARDIOGRAPHIC EPICARDIAL FAT THICKNESS AS A PREDICTOR FOR RECURRENCE OF PREGNANCY-INDUCED HYPERTENSION IN EGYPTIANS	115
CLINICAL CHARACTERISTICS, EVALUATION AND OUTCOMES OF CHYLOPERICARDIUM: A SYSTEMATIC REVIEW	115
DEVELOPMENT AND VALIDATION OF AN OUTCOME PREDICTION MODEL FOR REPAIRED TETRALOGY OF FALLOT: THE INDICATOR COHORT	115
DIAGNOSING CONGENITAL HEART DISEASE AT 63 YEARS OLD	114
ANOMALOUS LEFT CORONARY ARTERY ARISING FROM THE PULMONARY ARTERY (ALCAPA) WITH AN INTRAMURAL AORTIC COURSE: A RARE VARIANT OF A RARE ANOMALY PRESENTS AN IMAGING CHALLENGE	114
ASSOCIATION OF TRANSTHYRETIN VAL122ILE VARIANT WITH INCIDENT HEART FAILURE AND MORTALITY AMONG BLACK AMERICANS	111
SYSTEMIC RV FAILURE WITH SEPTAL BOWING AS A CAUSE OF SAM IN D-TRANSPOSITION OF THE GREAT ARTERIES	111

TCT-37 Impact of Bleeding During Dual Antiplatelet Treatment on Long-Term Prognosis in Patients Undergoing Percutaneous Coronary Intervention	110
IMPACT OF RELATIVE TEE GASTROESOPHAGEAL CONTRAINDICATIONS ON OUTCOMES IN HOSPITALIZATION UNDERGOING TEE	109
TRANSPOSED: MITRACLIP FOR TRICUSPID REGURGITATION IN L-LOOP TRANSPOSITION OF THE GREAT ARTERIES (L-TGA)	108
TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized Studies	106
IDIOPATHIC MASSIVE CORONARY ECTASIA IN THE SETTING OF AN ACUTE CORONARY SYNDROME	106
METABOLIC PROFILING OF HYPERTENSION IN 36,985 FINNISH INDIVIDUALS	106
SCALABLE DIGITAL SOLUTIONS TO ADDRESS PATIENT-CENTERED AMBULATORY CARDIOVASCULAR CARE IN THE GREATER ROCHESTER REGION	105
EXTREMELY LARGE AORTIC ANNULUS TAVR USING OVER-EXPANDED EDWARDS SAPIEN 3 VALVE WITH RENAL FUNCTION AND FUNCTIONAL CLASS IMPROVEMENT AFTER THE PROCEDURE.	105
LEAFLETS REMODELING, ANGULATION, AND TENTING IN ATRIAL FUNCTIONAL MITRAL REGURGITATION	103
COMPLICATIONS AND FAILURE MODES OF THE TURNPIKE CATHETERS: INSIGHTS FROM MAUDE DATABASE	103
CARDIOVASCULAR RISK AND ROUTE OF ESTROGEN ADMINISTRATION IN TRANSGENDER WOMEN: A SYSTEMATIC REVIEW AND META-ANALYSIS	103
OUTCOMES OF PREGNANCY IN WOMEN WITH CONGENITAL RIGHT VENTRICULAR OUTFLOW TRACT DYSFUNCTION	102
PREDICTORS OF ARRHYTHMIA RECURRENCE AFTER CATHETER ABLATION OF ATRIAL FIBRILLATION IN ELDERLY PATIENTS	102
TCTAP C-143 Mesenteric Venous Thrombosis With Abdominal Compartment Syndrome	101
IMPACT OF IN-HOSPITAL BLEEDING EVENTS ON MORTALITY IN STEMI PATIENTS WITH RADIAL PCI	101
WORSENING BLOOD PRESSURE CONTROL IS ASSOCIATED WITH DECREASED CARDIAC MECHANICS IN EARLY STAGE HER2 POSITIVE BREAST CANCER PATIENTS	100
STAGES OF CHRONIC KIDNEY DISEASE AND POST-PCI IN-HOSPITAL MORTALITY AMONG 6,884 PATIENTS ENTIRE SPECTRUM OF CORONARY ARTERY DISEASE PRESENTATION	100
TWO VARIANTS OF TAKOTSUBO CARDIOMYOPATHY IN A YOUNG WOMAN WITH ALCOHOL WITHDRAWAL	99
EXCESS EPICARDIAL FAT VOLUME REGARDLESS OF A LOW CORONARY ARTERY CALCIUM SCORE IS ASSOCIATED WITH HIGHER CARDIOVASCULAR RISK: TIME TO ASSESS EPICARDIAL FAT VOLUME IN ALL CARDIAC CT SCANS	99
ECHOCARDIOGRAPHY PERFORMANCE CHARACTERISTICS FOR BAFFLE COMPLICATIONS IN PATIENTS WITH D-TRANSPOSITION OF THE GREAT ARTERIES AND ATRIAL SWITCH OPERATION	99
MORTALITY TRENDS IN HEART FAILURE AND DIFFERENCES BY RACE AND SEX IN THE UNITED STATES: 1999 - 2019	98
TCT-90 Predictors of Device-Related Complications in Elderly Patients Requiring Mechanical Circulatory Support for Cardiogenic Shock Due to Acute Coronary Syndrome	98
TCT-32 ABSTRACT WITHDRAWN	97
HIDDEN VULNERABILITIES: THE USE OF OPTICAL COHERENCE TOMOGRAPHY FOR DELINEATION OF CULPRIT LESIONS IN MYOCARDIAL INFARCTION	97
A COMPLEX CASE OF FISTULOUS TRACT BETWEEN LEFT ANTERIOR DESCENDING ARTERY AND PULMONARY ARTERY	97
ASPIRIN-MEDIATED LYSINE ACETYLATION ALTERS SARCOMERIC MECHANICAL PROPERTIES IN CARDIOMYOCYTES	96
SAFETY AND EFFICACY OF COLCHICINE FOR SECONDARY PREVENTION AFTER ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	95
REGIONAL HETEROGENEITY OF EXERCISE-INDUCED CITED4 EXPRESSION IS SPATIALLY LINKED WITH CARDIAC MICROSTRUCTURAL REMODELING CHARACTERIZED BY DIFFUSION TENSOR CARDIAC MAGNETIC RESONANCE	95
TCT-34 Hemoglobin Drop in the Absence of Overt Bleeding After Percutaneous Coronary Intervention is Associated With In-Hospital Mortality	95
HEART-ENRICHED LONG NONCODING RNA NPPA-AS1 REGULATES PATHOLOGICAL CARDIAC HYPERTROPHY BY INITIATING A EP300-GATA4 AXIS	95
STROKE RISK IN HEART FAILURE AND ATRIAL FIBRILLATION - DOES EJECTION FRACTION MATTER?	94
GENDER DIFFERENCES IN REFERRAL PATTERNS FOR EVALUATION OF STABLE CORONARY ARTERY DISEASE (CAD) BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (CCTA)	92
A MASS-IVE MYSTERY: MULTIMODALITY IMPACT ON PATIENT OUTCOMES	92
IS SACUBITRIL/VALSARTAN LESS LIKELY TO BE PRESCRIBED IN ELDERLY PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION? A ROOT CAUSE ANALYSIS	89
TCT-307 In Vivo Characterization of Coronary Plaques: Findings From a Novel Hybrid Intravascular Ultrasound-Optical Coherence Tomography Intracoronary Imaging System	89
SUB-CLINICAL RIGHT VENTRICULAR DYSFUNCTION IN COVID-19 PATIENTS	88
A LARGE SINGLE TRANSMURAL CARDIAC RHABDOMYOMA IN A FETUS	88
A SUBTLE CASE OF CARDIAC AMYLOIDOSIS	87
TCTAP C-160 Optical Coherence Tomography Guided Percutaneous Coronary Intervention of Spontaneous Recanalized Coronary Thrombus	87
ADVANCED HEART FAILURE CHARACTERISTICS AND OUTCOMES IN PRIVATELY INSURED U.S. ADULTS	87
COMBINING SERUM PROTEOMIC WITH METABOLOMIC SEQUENCING TECHNOLOGY TO EXPLORE METABOLIC PATHWAYS RELATED TO CORONARY ARTERY DISEASE	85
THE ASSOCIATION BETWEEN CHANGES IN PEAK OXYGEN UPTAKE FOLLOWING PHASE II OUTPATIENT CARDIAC REHABILITATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS: A COMMUNITY COHORT	85
ISCHEMIA INDUCED BY A GIANT RIGHT CORONARY ARTERY ANEURYSM	84
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER	84
MATERNAL CARDIAC EVENTS AMONG PREGNANT WOMEN WITH M-WHO CLASS III AND IV AT THE FIRST CARDIO-OBSTETRIC CLINIC IN IRAQ	83
MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES (MINOCA) MIMICKERS IN ST-ELEVATION MYOCARDIAL INFARCTION	83
2D ECHOCARDIOGRAPHY IS SENSITIVE BUT NOT SPECIFIC FOR LEFT VENTRICULAR HYPERTROPHY IN HFPEF: COMPARISON WITH 3D ECHOCARDIOGRAPHY	82
TCT-169 Spontaneous Coronary Artery Dissection in Patients With and Without Chronic Systemic Inflammatory Diseases	82
A RARE CASE OF DRUG INDUCED ACUTE CORONARY SYNDROME FROM ORAL CAPECITABINE	82
UNEXPLAINED LEFT VENTRICULAR DYSFUNCTION: HOW IS CORONARY ANGIOGRAPHY USEFUL TODAY?	82
TCT-427 Renal Denervation Improves Renal Hemodynamic Status in Patients With Diabetes With Resistant Hypertension and Chronic Kidney Disease	81
INCREMENTAL VALUE OF PET SCAN IN THE EVALUATION OF PATIENTS WITH PREMATURE VENTRICULAR COMPLEXES	80
LEFT VENTRICULAR THROMBOSIS FORMATION IN THE PATIENT WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY FOLLOWING SARS-COV-2 INFECTION A CASE REPORT AND LITERATURE REVIEW	80
WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19	80
LEFT VENTRICLE BIOMECHANICS IN CLASSIC VERSUS LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS: TRANSLATIONAL APPLICATION OF COMPUTATIONAL MODELING	79
RECOVERY OF LEFT VENTRICULAR DYSFUNCTION IN HOSPITALIZED PATIENTS WITH COVID-19	79
NATIONWIDE TRENDS OF BALLOON PULMONARY ANGIOPLASTY AND PULMONARY THROMBOENDARTERECTOMY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	79
TCT-467 Protein-Energy Malnutrition Is Associated With Cardiac Arrest and a Longer Hospital Length of Stay in Patients Admitted With Transcatheter Mitral Valve Repair	79
RECURRENT CARDIOEMBOLIC STROKE IN A PATIENT WITH ATRIAL PALSY SYNDROME	79
LONG-TERM OUTCOMES AFTER SINGLE VERSUS DOUBLE STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY BIFURCATION LESIONS: AN UPDATED META-ANALYSIS	79
IMPACT OF EPICARDIAL FAT ON CLINICAL OUTCOMES IN COVID-19	78
THREE TIME LOSER OR THIRD TIME’S THE CHARM? OUTCOME OF REPEATED PERCUTANEOUS CORONARY INTERVENTION FOR RECURRENT RESTENOSIS AFTER TWO LAYERS OF DRUG-ELUTING STENTS	78
FLECAINIDE FOR ATRIAL FIBRILLATION: DON’T GET DEPRESSED	78
RELATIONSHIP OF C-PADDLE ORIENTATION AND HAT-MARKER POSITIONING WITH NEOCOMMISSURAL OVERLAP AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT	77
IMPACT OF SAPIEN 3 TRANSCATHETER AORTIC VALVE REPLACEMENT ON LEFT VENTRICULAR OUTFLOW TRACT AND MITRAL ANNULAR GEOMETRY - IMPLICATIONS ON TRANSCATHETER MITRAL VALVE REPLACEMENT	77
TCT-362 Comparison of Radial Versus Femoral Arterial Access for Complex Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis	76
A RARE CASE OF IVC SCARRING CAUSING UNPROVOKED DVT	76
PLASMA CERAMIDE LEVELS ARE ELEVATED IN PATIENTS WITH EARLY CORONARY ATHEROSCLEROSIS AND MICROVASCULAR ENDOTHELIAL DYSFUNCTION	76
THE PACEMAKER DECISION: MANAGEMENT OF COMPLETE HEART BLOCK IN HYPOTHYROIDISM	76
NOVEL USE OF SENTINEL CEREBRAL PROTECTION DURING THROMBOSED SEPTAL OCCLUDER EXPLANT AND ATRICLIP APPENDAGE CLOSURE	76
WHAT TO DO NEXT? DISCORDANCE BETWEEN TECHNITIUM PYROPHOSPHATE IMAGING AND CARDIAC BIOPSY FOR AL VERSUS ATTR CARDIAC AMYLOIDOSIS	76
META-ANALYSIS COMPARING OUTCOME COMPARISON BETWEEN DE-ESCALATED ANTIPLATELET THERAPY FROM TICAGRELOR TO CLOPIDOGREL AND CONTINUOUS THERAPY WITH TICAGRELOR FOR PATIENTS DIAGNOSED WITH ACUTE CORONARY SY	76
RISK FACTORS FOR HOSPITAL READMISSIONS AFTER PERCUTANEOUS PERIPHERAL INTERVENTIONS IN THE US-MEXICO BORDER	74
TCT-415 Predictors of New-Onset Atrial Fibrillation Following Transcatheter Mitral Valve Repair: Insights From the Nationwide Readmissions Database	74
COMPARISON OF LEFT VENTRICULAR EJECTION FRACTION CHANGE AND CARDIAC REMODELING IN YOUNG VERSUS ELDERLY PATIENTS AFTER FIRST-TIME ST-ELEVATION MYOCARDIAL INFARCTION	74
TCT-229 Impact of Coronary CT Image Quality on the Accuracy of the FFRCT Planner to Predict Fractional Flow Reserve After PCI	73
TCT-244 Impact of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization	73
TCT-263 Impact of MitraClip NT and XTW on Pressure Gradient	72
ORAL ANTICOAGULATION FOR THE PREVENTION OF CARDIOGENIC THROMBO-EMBOLIC EVENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION AND NEW-ONSET ANTERIOR WALL MOTION ABNORMALITIES	72
TCT-264 Role of Renal Denervation in Hypertension: An Updated Meta-Analysis of Randomized Sham Controlled Trials	71

USE OF COMMERCIAL CLAIMS DATA TO ESTIMATE TRANSTHYRETIN-AMYLOID CARDIOMYOPATHY PREVALENCE AND INCIDENCE IN THE US	71
FUELING THE INTIMAL TEAR	71
TCT-323 Is There a Difference in the Types of Complex High-Risk but Indicated Percutaneous Coronary Interventions (CHIP) Undertaken and Their Outcomes Among Different Racial Groups? Insights From a Na	70
INSULIN AUTOIMMUNE SYNDROME AFTER CORONARY STENT PLACEMENT	70
TEN-YEAR TRENDS IN PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY COMPLICATIONS IN THE US - THE NATIONAL INPATIENT SAMPLE (2008-2017)	69
TCT-326 In Vitro Performance of Thermoformed Polymeric Transcatheter Heart Valves	69
DIFFUSE ANEURYSMAL DISEASE SECONDARY TO NOVEL FLNA GENE MUTATIONS	68
HYPERTROPHIC CARDIOMYOPATHY WITHOUT HYPERTROPHY: MASQUERADERS OF OUTFLOW OBSTRUCTIVE PHYSIOLOGY WITH NORMAL LV MASS	68
SALVAGE CATHETER-DIRECTED THROMBOLYSIS FOR MASSIVE PULMONARY EMBOLISM CAUSED BY DISLODGED THROMBUS DURING THROMBECTOMY ATTEMPT FOR PHLEGMASIA CERULEA DOLENS	68
COLCHICINE ISN’T ALWAYS THE ANSWER!	67
NOVEL AUTOMATED CHA2DS2-VASC CALCULATOR HELPS DETERMINE HIGH-RISK PATIENTS FOR ANTICOAGULATION	67
CLEARED SARS-COV-2 INFECTION IS ASSOCIATED WITH LOWER RISK PULMONARY EMBOLISM	67
IMPACT OF INTERHOSPITAL TRANSFER ON OUTCOMES IN ACUTE PULMONARY EMBOLISM	67
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS MANIFESTING AS ACUTE CARDIOMYOPATHY	67
JOINT PAINS AND A RACING HEART- VENTRICULAR TACHYCARDIA AS AN INITIAL PRESENTATION OF UNDERLYING SCLERODERMA RELATED AUTOIMMUNE MYOCARDITIS	67
CTLA-4 AND PD-1 BLOCKING AGENTS EXERTES CARDIOTOXIC, PRO-FIBROTIC AND PRO-INFLAMMATORY EFFECTS IN CELLULAR AND PRECLINICAL MODELS	66
THE FONTAN PATHWAY: CHANGES IN DIMENSION AND CATHETER-BASED INTERVENTIONS OVER TIME	66
ONSET OF THE COVID-19 PANDEMIC REDUCED ACTIVE TIME IN PATIENTS WITH IMPLANTED PACEMAKERS	66
ASYMPTOMATIC COMPLETE ATRIOVENTRICULAR BLOCK IN AN ATHLETE	65
PREDICTORS OF CARDIAC REHABILITATION REFERRAL IN PATIENTS WITH MINOCA	65
USE OF SHAPE-HF SYSTEM FOR POINT-OF-CARE CARDIOPULMONARY EXERCISE TESTING OF PATIENTS WITH CTEPH AND CTED; A PRELIMINARY ANALYSIS	65
CASE SERIES OF PATIENTS UNDERGOING NOVEL MINI-THORACOTOMY EPICARDIAL LEAD PLACEMENT APPROACH FOR CARDIAC RESYNCHRONIZATION THERAPY	65
SYMPTOMATIC CORONARY ENDOTHELIAL DYSFUNCTION AFTER RECOVERY FROM COVID-19	65
CHEYNE STOKES BREATHING AND HEART FAILURE: THE PERFECT (VT) STORM?	65
SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD)—A “REAL-WORLD” LOOK AT HOW BEST PRACTICES ARE USED FROM THE VOICE OF THE PATIENT	64
LIFE IS A RODEO - STROKE AFTER MECHANICAL BULL RIDING	64
THE SAFETY OF PULMONARY VEIN ISOLATION IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC THROMBOCYTOPENIA-RESULTS FROM THE NATIONWIDE INPATIENT SAMPLE DATABASE	64
TCT-27 Abstract Withdrawn	64
TCT-294 A Novel Risk Score to Identify AF Patients Undergoing PCI at High Thrombotic Risk a RE-DUAL PCI Secondary Analysis	64
OUTCOMES OF ELDERLY PATIENTS WITH PULMONARY EMBOLISM UNDERGOING PERCUTANEOUS MECHANICAL THROMBECTOMY WITH INARI FLOWTRIEVER SYSTEM COMPARED WITH SYSTEMIC THROMBOLYSIS	63
GENDER DIFFERENCES AND OUTCOMES IN ACUTE CORONARY SYNDROMES ADMITTED TO AN EMERGENCY DEPARTMENT IN LATIN AMERICA	63
A RARE CASE OF SPONTANEOUS POSTERIOR DESCENDING ARTERY PERFORATION	63
TCT-302 Optical Coherence Tomography–Derived Changes in Plaque Structural Stress Over the Cardiac Cycle: A New Method for Plaque Biomechanical Assessment	63
RACE-SPECIFIC PHENOTYPIC AND GENOTYPIC COMPARISON OF PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS	63
UTILITY OF ADVANCED CARDIAC IMAGING IN DISCERNING ETIOLOGIES OF COMPLETE HEART BLOCK	63
COMPARISON OF BODY MASS INDEX ON SURVIVAL OUTCOME FOLLOWING HEART TRANSPLANTATION: A UNOS DATABASE ANALYSIS	62
TEMPORAL TRENDS IN NON-CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS HOSPITALIZED WITH ACUTE VS CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ARIC STUDY	61
PULMONARY HEMORRHAGE DURING VA-ECMO SUPPORT IN A PATIENT WITH A SYSTEMIC-PULMONARY ARTERY SHUNT	61
REAL WORLD OUTCOMES OF FLOWTRIEVER PULMONARY ARTERY THROMBECTOMY AT A TERTIARY CARE HOSPITAL	61
TCT-207 First Experience With the Novel Selution SLR Sirolimus-Eluting Balloon in All-Comer Patients Presenting With Acute and Chronic Coronary Artery Disease	60
PERCUTANEOUS ENDOVASCULAR TREATMENT FOR REPAIR OF LATE POSTSURGICAL COMPLICATIONS IN UNIVENTRICULAR PHYSIOLOGY	60
LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVEL OF 5MG/DL WITH ALIROCUMAB THERAPY - HOW LOW IS TOO LOW?	60
IMPACT OF HF HOSPITALIZATION ON MORTALITY OUTCOMES IN PATIENTS WITH HEART FAILURE WITH STABLE MID-RANGE EJECTION FRACTION	59
ADIPOSE TISSUE ADIPOKINE EXPRESSION IS LINKED TO METABOLIC RISK IN OBESITY	59
UNROOFING THE CAUSE OF PULMONARY HYPERTENSION AFTER BONE MARROW TRANSPLANTATION	59
FAMILIAL HYPERCHOLESTEROLEMIA AND ABDOMINAL AORTIC OBSTRUCTION IN A YOUNG WOMAN: A CASE REPORT	59
TREND OF MECHANICAL CIRCULATORY SUPPORT DEVICE USE IN PATIENTS WITH CARDIOGENIC SHOCK FROM NON-ISCHEMIC CAUSES	59
SEX DIFFERENCES IN DISTRIBUTION, MANAGEMENT AND OUTCOMES OF COMBINED ISCHEMIC-BLEEDING RISK FOLLOWING ACUTE CORONARY SYNDROME	59
Long-Duration Space Flight and Cardiac Morphology	58
Cardiovascular Care in the United States	58
Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers	58
Controlling Hypertension	58
Contents	58
Chest Compression-Only Cardiopulmonary Resuscitation in Pediatric Out-of-Hospital Cardiac Arrest	57
Reply	57
Dawn of the Era of Individualized Genetic Profiling in the Prevention of Sudden Cardiac Death	57
Audio Summary	57
Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid	56
Reaching for the Stars With the Least Number of Interventions Possible	56
Reply	56
Reply	55
Lipoprotein(a) Cholesterol Masquerading as Low-Density Lipoprotein Cholesterol	55
Contents	55
Hypertrophic Cardiomyopathy in the General Population	55
Contents	55
Contents	55
Reply	55
Contents	55
Contents	54
Another Road to Rome	54
Cardiac Arrest and Sudden Death	54
Game Theory, Health Care, and Economics	54
LONG-TERM LITHIUM CARBONATE USE AND HYPERTROPHIC CARDIOMYOPATHY. IS THERE A POSSIBLE LINK?	54
Audio Summary	54
BATTLING CRITICAL DECISIONS: AMLODIPINE TOXICITY, HIGH-OUTPUT HEART FAILURE, VASOPLEGIA, AND ECMO SUPPORT	53
INFECTIVE ENDOCARDITIS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT UNDERGOING SURGICAL MANAGEMENT: INSIGHTS FROM A TERTIARY CARE CENTER OF EXCELLENCE	53
The Lancet–JACC Collaboration	53
HIDDEN IN PLAIN SIGHT: A DECADE-LONG UNDETECTED PACEMAKER LEAD MISPLACEMENT	53
EVENTS OF MYOCARDIAL INFARCTION AMONG ADULTS WITH COCAINE OVERDOSE AND PREDICTORS OF MORTALITY; A RETROSPECTIVE STUDY INVOLVING 105695 CASES	53
Correction	53
GOOD PERICARDIUM GIVEN A BAD WRAP: A RESTRICTIVE CARDIOMYOPATHY MASQUERADING AS CONSTRICTIVE PERICARDITIS	53
CONCURRENT IMMUNE CHECKPOINT INHIBITOR INDUCED MYOCARDITIS & MYASTHENIA GRAVIS	53
Correction	53
LOST THE GRASP — A CASE OF MITRACLIP SINGLE-LEAFLET DETACHMENT	52
CORONARY ARTERY FISTULAE ARE ASSOCIATED WITH THE APICAL VARIANT OF HYPERTROPHIC CARDIOMYOPATHY	52
CARDIAC ARRHYTHMIA REGISTRY OF ATHLETES - THE EFFECTS OF CATHETER ABLATION ON QUALITY OF LIFE	52
Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock	52
A CASE OF AN ANOMALOUS RIGHT CORONARY ARTERY ARISING FROM A SINGLE CORONARY ARTERY ORIGIN	52
CONCURRENT PULMONARY FIBROSIS AND PULMONARY ARTERIAL HYPERTENSION APPROACHED BY CARDIOPULMONARY EXERCISE TESTING, AN ILLUSTRATIVE CASE REPORT	52
TACHY AND BRADY-ARRHYTHMIA MANAGEMENT IN COMPLEX CONGENITAL HEART DISEASE	52
Contents	51
CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME RISK FACTOR PREVALENCE, TREATMENT, AND CONTROL AMONG SOUTH ASIAN AND CHINESE AMERICANS	51
Correction	51
A RARE CASE OF SUCCESSFUL HEART TRANSPLANT IN A PATIENT WITH SPORADIC INCLUSION BODY MYOSITIS	51
EXPLORING STATIN UNDERUTILIZATION IN PATIENTS WITH LDL ≥ 190	51